OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,136,748 | +92.6% | 220,300 | +96.7% | 0.04% | +72.0% |
Q1 2023 | $590,240 | -2.1% | 112,000 | +85.7% | 0.02% | -43.2% |
Q3 2021 | $603,000 | -45.0% | 60,300 | -22.0% | 0.04% | -58.5% |
Q2 2021 | $1,096,000 | +791.1% | 77,311 | +377.2% | 0.11% | +324.0% |
Q3 2020 | $123,000 | – | 16,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |